JNJ vs AMGN
By Alex · Tickerpine
Johnson & Johnson vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | AMGN |
|---|---|---|
| Price | $273.14 | $442.24 |
| Market cap | $658.24B | $239.09B |
| P/E ratio | 31.7 | 27.5 |
| ROE | 25.74% | 91.47% |
| Profit margin | 21.48% | 22.95% |
| Revenue growth | 6.60% | 9.50% |
| Dividend yield | 1.96% | 2.28% |
| Beta | 0.23 | 0.41 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs AMGN in plain English
- JNJ is the bigger company — about 2.8× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.5 vs 31.7).
- AMGN earns a higher return on equity (91% vs 26%).
- AMGN is growing revenue faster (10% vs 7%).
- AMGN has the higher dividend yield (2.28% vs 1.96%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.